Spyre Therapeutics CEO Sells $739K in Shares: Spyre Therapeutics CEO Turtle Cameron sold $739,000 in stock, disclosed Apr 4, 2026; verify the Form 4 and context before drawing conclusions. 👈 Read full analysis #SpyreTherapeutics #TurtleCameron #StockMarket #CEO #InvestmentNews
0
0
0
0